Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with T-cell prolymphocytic leukemia (a rare type of blood cancer affecting white blood cells)
Who may not be able to join:
- People who have not signed the required consent form agreeing to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kamel LARIBI, Dr, French Innovative Leukemia Organisation
Phone: 3 20 44 57 13
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical characteristics of prolymphocytic leukemia T; Biological characteristics of prolymphocytic leukemia T; Flow cytometry data of bone marrow and blood cells; karyotype of tumor cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.